MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Dexcom adds COO to CFO Blackford’s title | Personnel Moves, September 19, 2019

Dexcom adds COO to CFO Blackford’s title | Personnel Moves, September 19, 2019

By

Dexcom COO & CFO Quentin Blackford (NSDQ:DXCM) this week added the COO role to CFO Quentin Blackford’s title.

Blackford is now in charge of Dexcom’s global supply chain, manufacturing operations and expansion into new markets, the San Diego-based company said. He’s been CFO of the continuous glucose monitor maker since 2017, when he left the chief finance spot at NuVasive (NSDQ:NUVA).

“We believe we are on the cusp of tremendous opportunities that will require discipline across our financial investments, resource allocation and business processes,” president & CEO Kevin Sayer said in prepared remarks. “In light of this, we are expanding Quentin’s role to include oversight of global manufacturing operations, supply chain management and expansion into new markets. We believe this expanded role will allow for better coordination across key business units that are critical to the realization of these opportunities.”

 Cerner lures Medtronic’s Johnson for chief marketing role
Cerner (NSDQ:CERN) this week lured Darrell Johnson away from Medtronic (NYSE:MDT) to be its first chief marketing officer.

Johnson, a 20-year veteran of the medtech industry, was the vice president of corporate data strategy at Medtronic and previously worked at GE Healthcare.

“I’m pleased to welcome Darrell to our team,” said Brent Shafer, chairman and CEO, Cerner. “His experience in market innovation, business transformation and global brand positioning makes him a perfect fit for this moment in Cerner’s history. Earlier this year, we introduced a new operating model focused on our clients’ success and we are in the early stages of a transformation that is driving faster, more scalable innovation. Darrell will provide critical leadership as the company pursues new growth strategies and introduces new solutions to the market.”
Read More

 Stereotaxis looks to finance VP Peery for new CFO
Stereotaxis (NSDQ:STXS) promoted finance VP Kimberly Peery to replace CFO Martin Stammer, effective Sept. 30.

“I appreciate the confidence placed in me by the Stereotaxis board of directors and look forward to becoming CFO in this exciting period for Stereotaxis,” said Peery, who joined the companyin 2003.

“I have really enjoyed my time at Stereotaxis and firmly believe in the future of the Company,” said Martin Stammer. “I have the utmost confidence in Kim and her team and look forward to seeing them achieve many additional milestones,” added Stammer, who’s slated to join a St. Louis professional services firm as CFO.

“I appreciate Marty’s contributions to Stereotaxis over many years and wish him well in his future endeavors. He leaves us in a strong position following our recently completed financing and uplisting to the NYSE American. I am excited to work with Kim and congratulate her on her new leadership role,” chairman & CEO David Fischel said.
Read More

 Zimmer Biomet taps Endo accounting chief Nichol for CAO
Zimmer Biomet (NYSE:ZBH) this week named Carrie Nichol as VP, controller & chief accounting officer, effective Oct. 1, replacing interim CAO Suketu Upadhyay, who will stay on as CFO.

Nichol was CAO at pharma giant Endo International (NSDQ:ENDP).Read More

 Microdermics names ex-Edwards CMO Duhay as CEO
Microdermics named Dr. Francis Duhay, the former chief medical officer at Edwards Lifesciences (NYSE:EW), to be its new CEO.

“Francis is a prominent and well-respected industry veteran and physician and has extensive experience that spans all aspects of the medical device industry, from running medical device businesses, to driving successful clinical programs, to performing medical procedures himself,” board member Lana Janes said in prepared remarks. “His expertise and insights will enable us to speed the development process for our unique platform technology that has the potential to both derive insights from the skin and deliver therapy.”

“I am intrigued by the duel opportunity inherent in the Microdermics microsensor platform,” Duhay added. “Having been involved in emerging medical businesses for more than 20 years and directly with patients long before that, the promise of a technology that makes monitoring a patient’s health condition and managing it easier and faster is the future. I look forward to bringing my experience to bear to drive the technology forward to success.”
Read More

In case you missed it

RSS From Medical Design & Outsourcing

  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]